Your setting describes a pretest-posttest-control group design, hence you should not use a (standardized) mean difference measure but a (standardized) measure of mean change. You can read a broad overview in Chapter 6 of the Cochrane Handbook and in Viechtbauer's documentation on conducting meta-analysis in R with the metafor package.
What is mean change? This is a non-trivial problem, in close connection with Lord's paradox. You have roughly three options (following Senn's and McKenzie et al.'s, 2015 taxonomy):
- Simple Analysis of Final Values (SAFV): $\bar{Y}^{Int}_{Tf} - \bar{Y}^{Con}_{Tf} $
- Simple Analysis of Change Score (SACS): $(\bar{Y}^{Int}_{Tf} - \bar{Y}^{Int}_{T0}) - (\bar{Y}^{Con}_{Tf} - \bar{Y}^{Con}_{T0}) $
- ANCOVA Effect Estimate: $(\bar{Y}^{Int}_{Tf} - \bar{Y}^{Con}_{Tf}) - \hat{\beta}(\bar{Y}^{Int}_{T0} - \bar{Y}^{Con}_{T0}) $
You can see McKenzie's et al. paper for a thorough comparison and formulas for the computation of the variances of measures. The general advice is to prefer the ANCOVA effect estimate, as both SAFV and SACS tend to be biased.
Regarding the variance, for both SACS and ANCOVA you need to have an estimate of the correlation between the pre and post measures (or, equivalently, the standard deviation of the change score), which is usually not reported. Once you have one of these values, you are ready to estimate the variance of the effect size, since
$r = \frac{SD^2_{T0} + SD^2_{Tf} - SD^2_{Change}}{2*SD_{T0}*SD_{Tf}}$ (Fu et al., 2008, p.15). In some cases, you may have the confidence interval of the change score, which is also sufficient following the indications in the Cochrane Handbook (7.7.3.2.).
Note
- The options are summarized as three here, but you can read more on different ways to set up the ANCOVA effect estimate and performance comparisons in O'Connell et al., 2017.
- If the pre-post correlation is larger than 0.5, SACS is prefered over SAFV (and vice-versa, Fu et al., 2008, p.9).